The histological course of nonalcoholic fatty liver disease in Japanese patients: Tight glycemic control, rather than weight reduction, ameliorates liver fibrosis

  1. Erika Hamaguchi, MD, PHD1,
  2. Toshinari Takamura, MD, PHD (ttakamura{at}m-kanazawa.jp)1,
  3. Masaru Sakurai, MD, PHD2,
  4. Eishiro Mizukoshi, MD, PHD3,
  5. Yoh Zen, MD, PHD4,
  6. Yumie Takeshita, MD, PHD1,
  7. Seiichiro Kurita, MD, PHD1,
  8. Kuniaki Arai, MD, PHD3,
  9. Tatsuya Yamashita, MD, PHD3,
  10. Motoko Sasaki, MD, PHD5,
  11. Yasuni Nakanuma, MD, PHD5 and
  12. Shuichi Kaneko, MD, PHD3
  1. 1 Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan
  2. 2 Department of Epidemiology and Public Health, Kanazawa Medical University, Ishikawa, Japan
  3. 3 Department of Gastroenterology, Kanazawa University Hospital, Ishikawa, Japan
  4. 4 Division of Pathology, Kanazawa University Hospital, Ishikawa, Japan
  5. 5 Department of Human Pathology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan

    Abstract

    Objective — The goal of this study was to examine whether metabolic abnormalities are responsible for the histological changes observed in Japanese patients with nonalcoholic fatty liver disease (NAFLD) who have undergone serial liver biopsies.

    Research design and methods — In total, 39 patients had undergone consecutive liver biopsies. Changes in their clinical data were analyzed, and biopsy specimens were scored histologically for stage.

    Results — The median follow-up time was 2.4 years (range, 1.0–8.5 years). Liver fibrosis had improved in 12 patients (30.7%), progressed in 11 patients (28.2%), and remained unchanged in 16 patients (41%). In a Cox proportional hazard model, decrease in A1C and use of insulin were associated with improvement of liver fibrosis independent of age, gender and BMI. However, ΔA1C was more strongly associated with the improvement of liver fibrosis than use of insulin after adjusted for each other (chi-square; 7.97 vs. 4.58, respectively).

    Conclusions — Tight glycemic control may prevent histological progression in Japanese patients with NAFLD.

    Footnotes

      • Received February 8, 2009.
      • Accepted October 20, 2009.

    This Article

    1. Published online before print October 30, 2009, doi: 10.2337/dc09-0148
    1. » Abstract
    2. Full Text (PDF)
    3. Online-Only Appendix

    Current Issue

    1. December 2009, 32 (12)
    1. Current Issue
    1. Alert me to new issues of Diabetes Care